The altered T cell landscape in systemic sclerosis patients is characterized by dysfunctional type 1 immunity
Open Access
- 2 November 2026
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (11)
Abstract
T cells in patients with chronic autoimmunity show features of dysfunction. However, the functionally defined T cell subsets that are affected by these changes remain poorly characterized. Here, we sought to reveal aberrations in the composition, phenotype, and function of canonical T cell subsets in the blood of systemic sclerosis (SSc) patients compared with healthy subjects and systemic lupus erythematosus (SLE) patients. Therefore, we developed a novel multidimensional flow-cytometry panel to simultaneously detect lineage-defining transcription factors, co-inhibitory receptors and other functional markers to characterize T cell subsets without in vitro restimulation. We compared T cell landscapes in SSc and SLE patients, and healthy subjects, using opt-SNE (optimized t-distributed stochastic neighbor embedding) and PhenoGraph algorithms. The data show altered distribution and aberrant functional states of transcription factor–defined T cell subsets in patients with autoimmunity, with shared and unique features between diseases and their subtypes. Strikingly, SSc and SLE patients showed deficiencies in subsets of CD8+ and CD4−CD8− T cells that expressed T-bet, which is critical for IFN-γ–dependent type 1 immunity. Moreover, TIGIT+Foxp3+ regulatory T cells, which suppress T helper 1 responses, were increased in diffuse cutaneous SSc and SLE patients. Functionally, T cells from SSc patients produced less IFN-γ, a cytokine that suppresses profibrotic gene expression in fibroblasts, as we demonstrate by transcriptomic analysis. Our study supports a model in which IFN-γ opposes canonical fibrotic gene programs in fibroblasts, and deficiencies in the IFN-γ–producing T cell compartment in SSc patients therefore may contribute to chronic fibrosis development. Aberrant T cell subsets in SSc and SLE represent targets for corrective immunotherapy.Keywords
Funding Information
- Walter and Marie Coyle research
- National Scleroderma Foundation (R21AR071580)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health (R21AR085863)
- National Institutes of Health (1R01HL155955)
- National Heart, Lung, and Blood Institute
- New Investigator Research
- National Scleroderma Foundation (R21AI185642)
- National Institute of Allergy and Infectious Diseases (R01AI127726)
- National Institute of Allergy and Infectious Diseases (R01AI169893)
- National Institute of Allergy and Infectious Diseases (R01AI130199)
This publication has 79 references indexed in Scilit:
- A PD‐1highCD4+ T Cell Population With a Cytotoxic Phenotype is Associated With Interstitial Lung Disease in Systemic SclerosisACR Open Rheumatology, 2024
- The relationship between peripheral T follicular helper cells and disease severity in systemic sclerosisClinical and Experimental Medicine, 2024
- Current Concepts on the Pathogenesis of Systemic SclerosisClinical Reviews in Allergy & Immunology, 2021
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus ErythematosusArthritis & Rheumatology, 2019
- Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD‐1, TIGIT, and TIM‐3 in Lymphocytes From Patients With Systemic SclerosisArthritis & Rheumatology, 2018
- OMIP‐037: 16‐color panel to measure inhibitory receptor signatures from multiple human immune cell subsetsCytometry Part A, 2016
- T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature ReviewClinical Reviews in Allergy & Immunology, 2015
- Interleukin‐13–producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosisArthritis & Rheumatism, 2012
- Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin‐13 associated with increased skin fibrosisArthritis & Rheumatism, 2009
- γδ Receptor Bearing T Cells in Scleroderma: Enhanced Interaction with Vascular Endothelial Cellsin VitroClinical Immunology, 1999